Lokaltherapie chronischer Wunden bei Patienten mit den ... - AWMF

S3-Leitlinie 091-001 „Lokaltherapie chronischer Wunden bei den Risiken CVI, PAVK und Diabetes mellitus“
285. Bishop JB, Phillips LG, Mustoe TA, VanderZee AJ, Wiersema L, Roach DE, et al. A prospective
randomized evaluator-blinded trial of two potential wound healing agents for the treatment of
venous stasis ulcers. Journal of Vascular Surgery. 1992;16(2):251-7.
286. Lazareth I, Meaume S, Sigal-Grinberg ML, Combemale P, Le Guyadec T, Zagnoli A, et al. The
role of a silver releasing lipido-colloid contact layer in venous leg ulcers presenting inflammatory
signs suggesting heavy bacterial colonization: results of a randomized controlled study. Wounds: A
Compendium of Clinical Research & Practice. 2008;20(6):158-66.
287. Wunderlich U, Orfanos CE. [Treatment of venous ulcera cruris with dry wound dressings.
Phase overlapping use of silver impregnated activated charcoal xerodressing]. Hautarzt.
1991;42(7):446-50. Epub 1991/07/01. Behandlung der Ulcera cruris venosa mit trockenen
Wundauflagen. Phasenubergreifende Anwendung eines Silber-impragnierten Aktivkohle-
Xerodressings.
288. Belcaro G, Cesarone MR, Errichi BM, Ricci A, Dugall M, Pellegrini L, et al. Venous and diabetic
ulcerations: management with topical multivalent silver oxide ointment. Panminerva Med. 2010;52(2
Suppl 1):37-42.
289. Storm-Versloot Marja N, Vos Cornelis G, Ubbink Dirk T, Vermeulen H. Topical silver for
preventing wound infection. Cochrane Database of Systematic Reviews: Reviews 2010 Issue 3 John
Wiley & Sons, Ltd Chichester, UK DOI: 101002/14651858CD006478pub2.
290. Jacobs AM, Tomczak R. Evaluation of Bensal HP for the treatment of diabetic foot ulcers. Adv
Skin Wound Care. 2008;21(10):461-5. Epub 2008/10/07.
291. Michaels JA, Campbell WB, King BM, Macintyre J, Palfreyman SJ, Shackley P, et al. A
prospective randomised controlled trial and economic modelling of antimicrobial silver dressings
versus non-adherent control dressings for venous leg ulcers: the VULCAN trial. Health TechnolAssess.
2009;13(56):1-114, iii.
292. Vasel - Biergans A, Probst W. Wundauflagen für die Kitteltasche. Stuttgart: Wissenschaftliche
Verlagsgesellschaft GmbH; 2006.
293. Sellmer W. Silberverbände. Ein neutraler Überblick. Vortrag Wundkongress Bremen, 10. Mai.
Wissenschaftliche Verlagsgesellschaft GmbH, zitiert
In: Vasel - Biergans A, Probst W, editors. Wundmanagement Ein illustrierter Leitfaden für Ärzte und
Apotheker
2ed. Stuttgart2009.
294. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in
skin in vivo and keratinocytes in vitro. EnvironHealth Perspect. 2010;118(3):407-13.
295. Schaller M, Laude J, Bodewaldt H, Hamm G, Korting HC. Toxicity and antimicrobial activity of
a hydrocolloid dressing containing silver particles in an ex vivo model of cutaneous infection. Skin
PharmacolPhysiol. 2004;17(1):31-6.
296. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns.
2004;30(2):140-7.
297. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, et al. A comparative study of the
cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models.
WoundRepair Regen. 2007;15(1):94-104.
298. Briggs M, Nelson EA. Topical agents or dressings for pain in venous leg ulcers.
CochraneDatabaseSystRev. 2010(4):CD001177.
299. Schaumverband mit Ibuprofen [database on the Internet]. 2010. Available from:
http://www.coloplast.de/produkte/wundversorgung/uebersichtnachproduktgruppen/schaumverban
dmitibuprofen/biatain%20ibu/anwendung/pages/anwendung.aspx.
300. Hinchliffe RJ, Valk GD, Apelqvist J, Armstrong DG, Bakker K, Game FL, et al. A systematic
review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in
diabetes. Diabetes/Metabolism Research and Reviews. 2008;24(Supplement 1):S119-S44.
Seite 268 von 279 aktueller Stand: 12.06.2012